These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21454456)

  • 21. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children.
    Kamya MR; Gasasira AF; Achan J; Mebrahtu T; Ruel T; Kekitiinwa A; Charlebois ED; Rosenthal PJ; Havlir D; Dorsey G
    AIDS; 2007 Oct; 21(15):2059-66. PubMed ID: 17885296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality.
    Manyanga VP; Minzi O; Ngasala B
    BMC Pharmacol Toxicol; 2014 Apr; 15():24. PubMed ID: 24761799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study.
    Arinaitwe E; Gasasira A; Verret W; Homsy J; Wanzira H; Kakuru A; Sandison TG; Young S; Tappero JW; Kamya MR; Dorsey G
    Malar J; 2012 Mar; 11():90. PubMed ID: 22453048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda.
    Orishaba P; Kalyango JN; Byakika-Kibwika P; Arinaitwe E; Wandera B; Katairo T; Muzeyi W; Nansikombi HT; Nakato A; Mutabazi T; Kamya MR; Dorsey G; Nankabirwa JI
    PLoS One; 2020; 15(11):e0240838. PubMed ID: 33175844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.
    Dow A; Kayira D; Hudgens M; Van Rie A; King CC; Ellington S; Kourtis A; Turner AN; Meshnick S; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
    Pediatr Infect Dis J; 2012 Aug; 31(8):842-7. PubMed ID: 22801093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
    Klement E; Pitché P; Kendjo E; Singo A; D'Almeida S; Akouete F; Akpaloo Y; Tossa K; Prince-Agbodjan S; Patassi A; Caumes E
    Clin Infect Dis; 2014 Mar; 58(5):651-9. PubMed ID: 24336820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.
    Laurens MB; Mungwira RG; Nampota N; Nyirenda OM; Divala TH; Kanjala M; Mkandawire FA; Galileya LT; Nyangulu W; Mwinjiwa E; Downs M; Tillman A; Taylor TE; Mallewa J; Plowe CV; van Oosterhout JJ; Laufer MK
    Clin Infect Dis; 2021 Sep; 73(6):1058-1065. PubMed ID: 33744963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
    Natureeba P; Kakuru A; Muhindo M; Ochieng T; Ategeka J; Koss CA; Plenty A; Charlebois ED; Clark TD; Nzarubara B; Nakalembe M; Cohan D; Rizzuto G; Muehlenbachs A; Ruel T; Jagannathan P; Havlir DV; Kamya MR; Dorsey G
    J Infect Dis; 2017 Jul; 216(1):29-35. PubMed ID: 28329368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.
    Mbeye NM; ter Kuile FO; Davies MA; Phiri KS; Egger M; Wandeler G;
    Trop Med Int Health; 2014 Sep; 19(9):1057-67. PubMed ID: 25039469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children.
    Kasule J; Gabriel EE; Anok A; Neal J; Eastman RT; Penzak S; Newell K; Serwadda D; Duffy PE; Reynolds SJ; Hobbs CV
    Am J Trop Med Hyg; 2018 Jun; 98(6):1718-1721. PubMed ID: 29692311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study.
    Mermin J; Were W; Ekwaru JP; Moore D; Downing R; Behumbiize P; Lule JR; Coutinho A; Tappero J; Bunnell R
    Lancet; 2008 Mar; 371(9614):752-9. PubMed ID: 18313504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.
    Manyando C; Njunju EM; D'Alessandro U; Van Geertruyden JP
    PLoS One; 2013; 8(2):e56916. PubMed ID: 23451110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.
    Davis NL; Barnett EJ; Miller WC; Dow A; Chasela CS; Hudgens MG; Kayira D; Tegha G; Ellington SR; Kourtis AP; van der Horst C; Jamieson DJ; Juliano JJ
    Clin Infect Dis; 2015 Aug; 61(3):368-74. PubMed ID: 25900173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa.
    Coutsoudis A; Pillay K; Spooner E; Coovadia HM; Pembrey L; Newell ML
    S Afr Med J; 2005 May; 95(5):339-45. PubMed ID: 15931449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
    Walker AS; Ford D; Gilks CF; Munderi P; Ssali F; Reid A; Katabira E; Grosskurth H; Mugyenyi P; Hakim J; Darbyshire JH; Gibb DM; Babiker AG
    Lancet; 2010 Apr; 375(9722):1278-86. PubMed ID: 20347483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children.
    Longwe H; Jambo KC; Phiri KS; Mbeye N; Gondwe T; Hall T; Tetteh KK; Drakeley C; Mandala WL
    PLoS One; 2015; 10(3):e0121643. PubMed ID: 25807475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
    Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
    Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda.
    Kilian AH; Jelinek T; Prislin I; Kabagambe G; Byamukama W; Mpigika G; Korte R; von Sonnenburg F
    Trans R Soc Trop Med Hyg; 1998; 92(2):197-200. PubMed ID: 9764333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study.
    Gill CJ; Mwanakasale V; Fox MP; Chilengi R; Tembo M; Nsofwa M; Chalwe V; Mwananyanda L; Mukwamataba D; Malilwe B; Champo D; Macleod WB; Thea DM; Hamer DH
    Bull World Health Organ; 2008 Dec; 86(12):929-38. PubMed ID: 19142293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.